CIK: 0001816307 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 14, 2023
Total Value ($000): $323,279 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ImmunoGen Inc | 1,420,000 | $26,795 | 8.3% | $17.62 | — | EQUITIES | 45253H101 |
| — | Merus NV | 589,255 | $15,515 | 4.8% | $19.70 | — | EQUITIES | N5749R100 |
| — | Morphic Holding Inc | 252,309 | $14,465 | 4.5% | $50.86 | — | EQUITIES | 61775R105 |
| SDGR | Schrodinger Inc | 286,169 | $14,286 | 4.4% | $25.19 | +34.2% | EQUITIES | 80810D103 |
| KRYS | Krystal Biotech Inc | 118,941 | $13,964 | 4.3% | $90.31 | +13.1% | EQUITIES | 501147102 |
| — | Intra-Cellular Therapies Inc | 198,723 | $12,583 | 3.9% | $54.36 | — | EQUITIES | 46116X101 |
| — | Akero Therapeutics Inc | 241,357 | $11,269 | 3.5% | $21.39 | — | EQUITIES | 00973Y108 |
| ORIC | Oric Pharmaceuticals Inc | 1,450,822 | $11,258 | 3.5% | $4.17 | +36.3% | EQUITIES | 68622P109 |
| — | Akero Therapeutics Inc | 236,500 | $11,040 | 3.4% | $21.39 | — | Call | 00973Y108 |
| MLTX | MoonLake Immunotherapeutics | 200,000 | $10,200 | 3.2% | $21.57 | +24.7% | EQUITIES | 61559X104 |
| BIIB | Biogen Idec Inc | 26,854 | $7,649 | 2.4% | $291.36 | +2.2% | EQUITIES | 09062X103 |
| — | 89bio Inc | 396,497 | $7,514 | 2.3% | $15.23 | — | EQUITIES | 282559103 |
| COGT | Cogent Biosciences Inc | 620,000 | $7,341 | 2.3% | $11.30 | +1.5% | EQUITIES | 19240Q201 |
| ACRS | Aclaris Therapeutics Inc | 651,400 | $6,755 | 2.1% | $15.96 | -43.3% | Call | 00461U105 |
| UTHR | United Therapeutics Corp | 30,029 | $6,629 | 2.1% | $214.25 | +3.4% | EQUITIES | 91307C102 |
| MGNX | MacroGenics Inc | 1,215,675 | $6,504 | 2.0% | $5.66 | +9.0% | EQUITIES | 556099109 |
| KALV | KalVista Pharmaceuticals Inc | 720,508 | $6,485 | 2.0% | $7.46 | +23.6% | EQUITIES | 483497103 |
| VCYT | Veracyte Inc | 229,451 | $5,844 | 1.8% | $30.03 | -19.3% | EQUITIES | 92337F107 |
| — | Mirati Therapeutics Inc | 150,000 | $5,420 | 1.7% | $36.13 | — | Call | 60468T105 |
| BCRX | BioCryst Pharmaceuticals Inc | 760,904 | $5,357 | 1.7% | $10.58 | -24.1% | EQUITIES | 09058V103 |
| TERN | Terns Pharmaceuticals Inc | 599,668 | $5,247 | 1.6% | $6.60 | +76.7% | EQUITIES | 880881107 |
| — | Poseida Therapeutics Inc | 2,945,948 | $5,185 | 1.6% | $3.50 | — | EQUITIES | 73730P108 |
| NUVL | Nuvalent Inc | 115,067 | $4,852 | 1.5% | $26.36 | +43.4% | EQUITIES | 670703107 |
| GILD | Gilead Sciences Inc | 60,448 | $4,659 | 1.4% | $71.32 | +1.8% | EQUITIES | 375558103 |
| VRTX | Vertex Pharmaceuticals Inc | 13,175 | $4,636 | 1.4% | $240.06 | +40.4% | EQUITIES | 92532F100 |
| TELA | Tela Bio Inc | 416,440 | $4,219 | 1.3% | $10.33 | -1.0% | EQUITIES | 872381108 |
| VKTX | Viking Therapeutics Inc | 258,595 | $4,192 | 1.3% | $10.33 | +102.8% | EQUITIES | 92686J106 |
| — | Praxis Precision Medicines Inc | 3,476,162 | $3,998 | 1.2% | $1.15 | — | EQUITIES | 74006W108 |
| XENE | Xenon Pharmaceuticals Inc | 99,756 | $3,841 | 1.2% | $29.94 | +32.7% | EQUITIES | 98420N105 |
| — | Mersana Therapeutics Inc | 1,100,000 | $3,619 | 1.1% | $4.24 | — | Call | 59045L106 |
| OLMA | Olema Pharmaceuticals Inc | 390,466 | $3,526 | 1.1% | $6.04 | 0.0% | EQUITIES | 68062P106 |
| SRPT | Sarepta Therapeutics Inc | 29,860 | $3,420 | 1.1% | $129.09 | -0.2% | EQUITIES | 803607100 |
| PRTA | Prothena Corporation PLC | 49,721 | $3,395 | 1.1% | $64.50 | 0.0% | EQUITIES | G72800108 |
| — | Mirati Therapeutics Inc | 91,213 | $3,296 | 1.0% | $36.13 | — | EQUITIES | 60468T105 |
| — | Mersana Therapeutics Inc | 1,000,000 | $3,290 | 1.0% | $4.24 | — | EQUITIES | 59045L106 |
| INSM | Insmed Inc | 144,464 | $3,048 | 0.9% | $27.01 | -29.7% | EQUITIES | 457669307 |
| PHVS | Pharvaris NV | 200,000 | $3,028 | 0.9% | $8.17 | +17.8% | EQUITIES | N69605108 |
| ANIP | ANI Pharmaceuticals Inc | 54,041 | $2,909 | 0.9% | $44.33 | 0.0% | EQUITIES | 00182C103 |
| PHAT | Phathom Pharmaceuticals Inc | 200,000 | $2,864 | 0.9% | $8.78 | +31.3% | EQUITIES | 71722W107 |
| CERS | Cerus Corp | 1,158,265 | $2,849 | 0.9% | $5.67 | -58.1% | EQUITIES | 157085101 |
| MIRM | Mirum Pharmaceuticals Inc | 106,375 | $2,752 | 0.9% | $22.79 | +16.7% | EQUITIES | 604749101 |
| ACRS | Aclaris Therapeutics Inc | 219,229 | $2,273 | 0.7% | $15.96 | -43.3% | EQUITIES | 00461U105 |
| INCY | Incyte Corp | 34,110 | $2,123 | 0.7% | $78.23 | -14.6% | EQUITIES | 45337C102 |
| TRVI | Trevi Therapeutics Inc | 885,924 | $2,117 | 0.7% | $3.14 | -19.8% | EQUITIES | 89532M101 |
| NTLA | Intellia Therapeutics Inc | 50,858 | $2,074 | 0.6% | $54.04 | -25.0% | EQUITIES | 45826J105 |
| PLRX | Pliant Therapeutics Inc | 107,267 | $1,944 | 0.6% | $19.50 | +21.4% | EQUITIES | 729139105 |
| RYTM | Rhythm Pharmaceuticals Inc | 116,168 | $1,916 | 0.6% | $18.05 | 0.0% | EQUITIES | 76243J105 |
| — | CymaBay Therapeutics Inc | 160,000 | $1,752 | 0.5% | $10.95 | — | EQUITIES | 23257D103 |
| — | Ambrx Biopharma Inc | 100,000 | $1,646 | 0.5% | $16.46 | — | EQUITIES | 02290A102 |
| CUE | Cue Biopharma Inc | 403,402 | $1,472 | 0.5% | $3.26 | +20.2% | EQUITIES | 22978P106 |
| CLYM | Eliem Therapeutics Inc | 494,089 | $1,383 | 0.4% | $4.94 | -38.5% | EQUITIES | 28658R106 |
| ANNX | Annexon Inc | 389,911 | $1,372 | 0.4% | $4.37 | 0.0% | EQUITIES | 03589W102 |
| ZURA | Zura Bio Ltd | 160,000 | $1,312 | 0.4% | $8.03 | 0.0% | EQUITIES | G9TY5A101 |
| — | Reata Pharmaceuticals Inc | 12,500 | $1,275 | 0.4% | $101.96 | — | EQUITIES | 75615P103 |
| ALKS | Alkermes Plc | 40,000 | $1,252 | 0.4% | $30.28 | 0.0% | EQUITIES | G01767105 |
| VYGR | Voyager Therapeutics Inc | 100,000 | $1,145 | 0.4% | $11.45 | — | EQUITIES | 92915B106 |
| VRDN | Viridian Therapeutics Inc | 45,000 | $1,071 | 0.3% | $30.23 | -15.2% | EQUITIES | 92790C104 |
| RZLT | Rezolute Inc | 499,544 | $989 | 0.3% | $2.06 | 0.0% | EQUITIES | 76200L309 |
| — | Karyopharm Therapeutics Inc | 518,985 | $929 | 0.3% | $3.89 | — | EQUITIES | 48576U106 |
| — | Allakos Inc | 200,000 | $872 | 0.3% | $6.51 | — | EQUITIES | 01671P100 |
| BMRN | BioMarin Pharmaceutical Inc | 10,000 | $867 | 0.3% | $94.11 | 0.0% | EQUITIES | 09061G101 |
| BBIO | Bridgebio Pharma Inc | 50,000 | $860 | 0.3% | $12.34 | +22.0% | EQUITIES | 10806X102 |
| — | Point Biopharma Global Inc | 93,700 | $849 | 0.3% | $7.62 | — | EQUITIES | 730541109 |
| VTYX | Ventyx Biosciences Inc | 25,000 | $820 | 0.3% | $38.88 | -11.3% | EQUITIES | 92332V107 |
| PTGX | Protagonist Therapeutics Inc | 25,000 | $691 | 0.2% | $16.79 | +49.0% | EQUITIES | 74366E102 |
| — | Jasper Therapeutics Inc | 500,000 | $685 | 0.2% | $1.81 | — | EQUITIES | 471871103 |
| — | Aligos Therapeutics Inc | 631,887 | $614 | 0.2% | $0.87 | — | EQUITIES | 01626L105 |
| BHVN | Biohaven Ltd | 20,000 | $478 | 0.1% | $17.21 | 0.0% | EQUITIES | G1110E107 |
| SNDX | Syndax Pharmaceuticals Inc | 20,000 | $419 | 0.1% | $20.82 | 0.0% | EQUITIES | 87164F105 |
| CGEN | Compugen Ltd | 330,188 | $376 | 0.1% | $0.87 | -0.1% | EQUITIES | M25722105 |
| IMTX | Immatics Nv | 30,715 | $354 | 0.1% | $10.84 | -13.9% | EQUITIES | N44445109 |
| CLDX | Celldex Therapeutics Inc | 10,000 | $339 | 0.1% | $40.09 | -15.9% | EQUITIES | 15117B202 |
| — | FibroGen Inc | 100,000 | $271 | 0.1% | — | — | Call | 31572Q808 |
| — | Clene Inc | 250,000 | $220 | 0.1% | $0.88 | — | EQUITIES | 185634102 |
| GLUE | Monte Rosa Therapeutics Inc | 31,156 | $213 | 0.1% | $6.95 | -7.0% | EQUITIES | 61225M102 |
| ELOX | Eloxx Pharmaceuticals Inc | 54,075 | $210 | 0.1% | $4.22 | +51.8% | EQUITIES | 29014R202 |
| — | Pieris Pharmaceuticals Inc | 961,338 | $159 | 0.0% | $0.17 | — | EQUITIES | 720795103 |
| — | Evogene Ltd | 100,000 | $107 | 0.0% | $1.07 | — | EQUITIES | M4119S104 |
| GKOS | Glaukos Corp | 1,000 | $71 | 0.0% | $57.41 | 0.0% | EQUITIES | 377322102 |
| VRAYQ | Viewray Inc | 100,000 | $35 | 0.0% | $3.87 | -73.2% | EQUITIES | 92672L107 |
| RCKTW | Rocket Pharmaceuticals Inc | 104,828 | $20 | 0.0% | $0.11 | — | WARRANTS | 77313F114 |
| — | Fresh Tracks Therapeutics Inc | 10,000 | $7 | 0.0% | $1.50 | — | EQUITIES | 10802T204 |